 SAN DIEGO NEW YORK--BUSINESS WIRE--- FBIO ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of Fortress Biotech, Inc. NASDAQ: FBIO filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between December 11, 2019 and October 9, 2020. Fortress Biotech develops and commercializes pharmaceutical and biotechnology products. If you suffered a loss due to Fortress Biotech, Inc.s misconduct, 